Clinical Trial Update: Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating 7 days of celecoxib pretreatment in patients with surgically resected colorectal adenomas and carcinomas; the trial is completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenoma
• Colorectal Cancer

Drugs mentioned

• CELEBREX (Celecoxib)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Colorectal Adenoma, Colorectal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2014-08-07